Malaria antibody persistence correlates with duration of exposure

Vox Sanguinis

Volumn 104, Issue 4, 2013, Pages 292-298

  Faddy, H M ^a   Seed, C R ^a   Faddy, M J ^b   Flower, R L ^a   Harley, R J ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Antibody persistence; Blood donor; Malaria

Indexed keywords

ANTIBODY; MALARIA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SCREENING; ARTICLE; AUSTRALIA; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; EXPOSURE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALARIA; MALE; PRIORITY JOURNAL; SAMPLING; SEROCONVERSION; SURVIVAL; SURVIVAL RATE;

ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; BLOOD DONORS; BLOOD TRANSFUSION; DONOR SELECTION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALARIA; MALE; PLASMODIUM; TIME FACTORS;

EID: 84876732404     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12000     Document Type: Article

References (18)

1. Kitchen AD, Chiodini PL: Malaria and blood transfusion. Vox Sang 2006; 90:77-84.
2. Kitchen AD, Barbara JA, Hewitt PE: Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines. Vox Sang 2005; 89:77-80.
3. Bruneel F, Thellier M, Eloy O, et al.: Transfusion-transmitted malaria. Intensive Care Med 2004; 30:1851-1852.
4. Mungai M, Tegtmeier G, Chamberland M, et al.: Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344:1973-1978.
5. Frey-Wettstein M, Maier A, Markwalder K, et al.: A case of transfusion transmitted malaria in Switzerland. Swiss Med Wkly 2001; 131:320.
6. Garraud O, Assal A, Pelletier B, et al.: Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang 2008; 95:226-231.
7. Kitchen AD, Lowe PH, Lalloo K, et al.: Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical use. Vox Sang 2004; 87:150-155.
8. Seed CR, Kee G, Wong T, et al.: Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria. Vox Sang 2010; 98:e182-e192.
9. Hanna JN, Ritchie SA, Eisen DP, et al.: An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002. Med J Aust 2004; 180:24-28.
10. Fitzsimmons GJ, Wright P, Johansen CA, et al.: Arboviral diseases and malaria in Australia, 2008-09: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell 2010; 34:225-240.
11. Stickland JF, Roberts AN, Williams V: Transfusion-induced malaria in Victoria. Med J Aust 1992; 157:499-500.
12. Park CG, Chwae YJ, Kim JI, et al.: Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax. Am J Trop Med Hyg 2000; 62:720-725.
13. Morais CG, Soares IS, Carvalho LH, et al.: Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity. Am J Trop Med Hyg 2006; 75:582-587.
14. Bouchaud O, Cot M, Kony S, et al.: Do African immigrants living in France have long-term malarial immunity?Am J Trop Med Hyg 2005; 72:21-25.
15. Seed CR, Kitchen A, Davis TM: The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev 2005; 19:229-240.
16. Cheng A, Seed CR, Ismay S, et al.: Malaria antibody testing of Australian blood donors. Vox Sang 2011; 100:252-253.
17. Seed CR, Cheng A, Davis TM, et al.: The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria. Vox Sang 2005; 88:98-106.
18. Theunissen C, Janssens P, Demulder A, et al.: Falciparum malaria in patient 9years after leaving malaria-endemic area. Emerg Infect Dis 2009; 15:115-116.